Back to Search
Start Over
Japan - Eisai: Additional Detailed Analyses from Phase 2 Study 201 of Lecanemab Published as Three Papers in Peer-Reviewed Journals
- Source :
- Web News Wire. April 1, 2023
- Publication Year :
- 2023
-
Abstract
- India, April 1 -- Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that three additional detailed analyses from the Phase IIb clinical study (Study 201), evaluating the efficacy [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Web News Wire
- Publication Type :
- News
- Accession number :
- edsgcl.743843890